13F filer · CIK 1697748 ↗
ARK Invest
You are looking at Q2 2024. See the latest, Q2 2026 →
Reported value
$11.27B
−22% on the quarter before
Positions
190
10 new · 50 sold out
Top 10
49.0%
of the value
Est. gain
−$1.22B
on stocks held all quarter
Est. return
−10.1%
on those stocks since Q1 2024
Positions as of Jun 30, 2024, from ARK Invest's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2024. Striped tiles are options.
Largest buys
Since Q1 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- 10x Genomics Inc~$58.9MAdded · 1.6% → 1.6%+3,029,951 shares
- Roblox~$56.5MAdded · 3.1% → 4.4%+1,519,591 shares
- Ark 21shares Bitcoin ETF~$30.4MAdded · 1.4% → 1.8%+506,347 shares
- Pagerduty Inc~$27.1MAdded · 1.5% → 2.2%+1,180,202 shares
- Tesla~$26.9MAdded · 6.3% → 9.3%+135,966 shares
- Recursion Pharmaceuticals Inc~$26.7MAdded · 1.7% → 1.9%+3,555,357 shares
- Shopify Inc~$24.6MAdded · 2.5% → 2.9%+372,751 shares
- Tempus AI~$18.3MNew · 0.0% → 0.2%+522,698 shares
- Intellia Therapeutics Inc~$13.6MAdded · 2.1% → 2.3%+606,507 shares
- Datadog~$11.4MNew · 0.0% → 0.1%+87,737 shares
Largest sells
Since Q1 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Zoom~$225.4MCut · 2.9% → 1.3%−3,808,502 shares
- Coinbase~$191.6MCut · 8.1% → 7.0%−862,312 shares
- Robinhood~$160.0MCut · 3.7% → 3.9%−7,044,713 shares
- Exact Sciences Corp~$123.5MCut · 1.6% → 0.1%−2,923,161 shares
- Block~$113.6MCut · 5.9% → 4.7%−1,761,827 shares
- Draftkings Inc~$96.5MCut · 2.7% → 2.1%−2,527,105 shares
- Teladoc Health Inc~$83.7MCut · 1.7% → 0.6%−8,553,415 shares
- Adyen Nv~$58.0MSold out · 0.4% → 0.0%−34,257 shares
- Ginkgo Bioworks Holdings Inc~$55.4MCut · 1.5% → 0.1%−165,755,703 shares
- Twilio~$53.5MCut · 0.4% → 0.0%−942,634 shares
Holdings
As of Jun 30, 2024. Changes are in shares against Mar 31, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TeslaCommon Stock · shares +2.6% · price +12.6% | 9.3% | $1.05B | +$114.4M | ||||||||
| CoinbaseCommon Stock · shares −20% · price −16.2% | 7.0% | $790.9M | −$152.6M | ||||||||
| Roku IncCommon Stock · shares +1.3% · price −8.0% | 6.8% | $762.1M | −$65.8M | ||||||||
| BlockCommon Stock · shares −18% · price −23.8% | 4.7% | $534.8M | −$166.6M | ||||||||
| RobloxCommon Stock · shares +13% · price −2.5% | 4.4% | $496.3M | −$11.5M | ||||||||
| RobinhoodCommon Stock · shares −27% · price +12.8% | 3.9% | $435.0M | +$49.4M | ||||||||
| Crispr Therapeutics AgCommon Stock · shares −4.6% · price −20.8% | 3.7% | $420.1M | −$110.1M | ||||||||
| UiPathCommon Stock · shares −5.9% · price −44.1% | 3.3% | $377.2M | −$297.2M | ||||||||
| PalantirCommon Stock · shares +2.2% · price +10.1% | 2.9% | $329.9M | +$29.6M | ||||||||
| Shopify IncCommon Stock · shares +8.1% · price −14.4% | 2.9% | $328.1M | −$51.1M | ||||||||
| Twist Bioscience CorpCommon Stock · shares −12% · price +43.6% | 2.7% | $302.1M | +$91.8M | ||||||||
| Intellia Therapeutics IncCommon Stock · shares +5.5% · price −18.6% | 2.3% | $259.5M | −$56.4M | ||||||||
| Pagerduty IncCommon Stock · shares +13% · price +1.1% | 2.2% | $243.2M | +$2.4M | ||||||||
| TeradyneCommon Stock · shares −9.6% · price +31.4% | 2.1% | $236.2M | +$56.5M | ||||||||
| Draftkings IncCommon Stock · shares −29% · price −15.9% | 2.1% | $236.2M | −$44.8M | ||||||||
| MetaCommon Stock · shares −0.6% · price +3.8% | 1.9% | $218.7M | +$8.1M | ||||||||
| Recursion Pharmaceuticals IncCommon Stock · shares +14% · price −24.8% | 1.9% | $211.1M | −$60.7M | ||||||||
| Ark 21shares Bitcoin ETFETP · shares +17% · price −15.5% | 1.8% | $204.9M | −$32.0M | ||||||||
| Pinterest IncCommon Stock · shares −11% · price +27.1% | 1.7% | $190.8M | +$40.7M | ||||||||
| Unity Software IncCommon Stock · shares −19% · price −39.1% | 1.6% | $183.8M | −$118.0M | ||||||||
| 10x Genomics IncCommon Stock · shares +48% · price −48.2% | 1.6% | $181.2M | −$113.6M | ||||||||
| Beam Therapeutics IncCommon Stock · shares −6.8% · price −29.1% | 1.6% | $178.7M | −$73.3M | ||||||||
| The Trade DeskCommon Stock · shares −12% · price +11.7% | 1.6% | $177.6M | +$18.6M | ||||||||
| ZoomCommon Stock · shares −60% · price −9.5% | 1.3% | $149.3M | −$15.6M | ||||||||
| Veracyte IncCommon Stock · shares −3.3% · price −2.2% | 1.3% | $147.6M | −$3.3M | ||||||||
| Total · 190 positions | 100% | $11.27B | −$1.22B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2024 to Q2 2024: 179 stocks held throughout, down $1.22B (−10.1%).
- Tesla+$114.4M+13%
- Twist Bioscience Corp+$91.8M+44%
- Teradyne+$56.5M+31%
- Robinhood+$49.4M+13%
- Pinterest Inc+$40.7M+27%
- 10x Genomics Inc−$113.6M−48%
- Unity Software Inc−$118.0M−39%
- Coinbase−$152.6M−16%
- Block−$166.6M−24%
- UiPath−$297.2M−44%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $15.40B+20% | SEC ↗ |
| Q1 2026 | May 12, 2026 | $12.86B−15% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $15.07B−10% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $16.80B+23% | SEC ↗ |
| Q2 2025 | Jul 30, 2025 | $13.64B+37% | SEC ↗ |
| Q1 2025 | May 7, 2025 | $9.99B−17% | SEC ↗ |
| Q4 2024 | Feb 4, 2025 | $12.01B+10% | SEC ↗ |
| Q3 2024 | Oct 31, 2024 | $10.93B−3% | SEC ↗ |
| Q2 2024 | Jul 26, 2024 | $11.27B−22% | SEC ↗ |
| Q1 2024 | Apr 18, 2024 | $14.44B−14% | SEC ↗ |
| Q4 2023 | Jan 17, 2024 | $16.89B+29% | SEC ↗ |
| Q3 2023 | Oct 18, 2023 | $13.07B−13% | SEC ↗ |
| Q2 2023 | Jul 10, 2023 | $15.10B+4% | SEC ↗ |
| Q1 2023 | Apr 17, 2023 | $14.55B+26% | SEC ↗ |
| Q4 2022 | Jan 24, 2023 | $11.54B−20% | SEC ↗ |
| Q3 2022 | Oct 17, 2022 | $14.35B−15% | SEC ↗ |
| Q2 2022 | Jul 11, 2022 | $16.91B−29% | SEC ↗ |
| Q1 2022 | Apr 18, 2022 | $23.96B−28% | SEC ↗ |
| Q4 2021 | Jan 28, 2022 | $33.08B−21% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $41.64B−23% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 | $53.74B+7% | SEC ↗ |
| Q1 2021 | May 13, 2021 | $50.34B+34% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $37.59B+123% | SEC ↗ |
| Q3 2020 | Oct 30, 2020 | $16.86B+81% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $9.30B+132% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $4.01B+1% | SEC ↗ |
| Q4 2019 | Jan 31, 2020 | $3.96B−13% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $4.58B+15% | SEC ↗ |
| Q2 2019 | Jul 30, 2019 | $3.97B+13% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $3.50B+42% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 (amended) | $2.46B−26% | SEC ↗ |
| Q3 2018 | Nov 7, 2018 | $3.31B+21% | SEC ↗ |
| Q2 2018 | Aug 7, 2018 | $2.73B+36% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $2.01B+60% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $1.26B+53% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $819.3M+60% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $513.6M+48% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $346.9M+26% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 | $274.9M | SEC ↗ |